These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4401812)

  • 21. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade.
    Nayler WG; Carson V
    Cardiovasc Res; 1973 Jan; 7(1):22-9. PubMed ID: 4144407
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 24. [Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
    Meier M; Hedwall PR; Imhof P; Wilhelm M; Brunner H
    Arzneimittelforschung; 1970 Dec; 20(12):1890-6. PubMed ID: 4395650
    [No Abstract]   [Full Text] [Related]  

  • 25. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the nature of the bronchial -adrenoreceptors.
    Boissier JR; Advenier C; Giudicelli JF; Viars P
    Eur J Pharmacol; 1971 Jun; 15(1):101-9. PubMed ID: 4143978
    [No Abstract]   [Full Text] [Related]  

  • 29. Simulated alpha-blockade due to inhibition of release of nor-epinephrine by a beta-blocking agent Ko 592.
    Redisch W; Clauss RH; Terry EN; Rouen L
    J Cardiovasc Surg (Torino); 1970; 11(2):141-5. PubMed ID: 4394165
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of isoproterenol, isoetharine and butyletharine on beta receptors.
    Levy B
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):144-52. PubMed ID: 4148406
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on cardiovascular drugs. XII. Pharmacological properties of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
    Imamura H; Nakamura T; Inui J; Yasuda H; Osuga K
    Yakugaku Zasshi; 1972 Aug; 92(8):1039-51. PubMed ID: 4404839
    [No Abstract]   [Full Text] [Related]  

  • 34. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist.
    Pendleton RG; Petta JM; Hahn RA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological studies with tiprenolol and propranolol in man.
    Kesteloot H; Sluyts R; Floor-Wieringa A; van Strik R
    Eur J Pharmacol; 1973 Mar; 21(3):257-63. PubMed ID: 4145318
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of alprenolol, bunolol and propranolol on pulmonary resistance in the anaesthetized dog.
    Giles RE; Finkel MP
    Eur J Pharmacol; 1971 Oct; 16(2):155-63. PubMed ID: 4405779
    [No Abstract]   [Full Text] [Related]  

  • 38. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 39. Guinea-pig atrial and pulmonary beta-adrenoceptors.
    Spilker BA; McKeon WB; Arnold A
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):220-30. PubMed ID: 4151237
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.